ENROXIL 50 MG/ML SOLUTION FOR INJECTION FOR CALVES, PIGS AND DOGS
Land: Ierland
Taal: Engels
Bron: HPRA (Health Products Regulatory Authority)
Productkenmerken
(SPC)
28-04-2015
Sommige documenten voor dit product zijn momenteel niet beschikbaar, u kunt een verzoek sturen naar onze klantenservice en we zullen u hiervan op de hoogte stellen zodra we ze kunnen verkrijgen.
Verzend verzoek.
Verzend verzoek.
Werkstoffen:
ENROFLOXACIN
Beschikbaar vanaf:
Krka, d.d., Novo mesto
ATC-code:
QJ01MA90
INN (Algemene Internationale Benaming):
ENROFLOXACIN
Dosering:
50 Mg/Ml
farmaceutische vorm:
Solution for Injection
Prescription-type:
POM
Therapeutische categorie:
Bovine, Canine, Porcine
Therapeutisch gebied:
Enrofloxacin
therapeutische indicaties:
Antibacterial
Autorisatie-status:
Authorised
Autorisatie datum:
2009-07-10
Productkenmerken
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
ENROXIL 50 mg/ml solution for injection for calves, pigs and dogs.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Solution for injection.
Clear yellow solution practically free from particles.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle, pigs, dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Calves:
Treatment of infections of the respiratory tract caused by enrofloxacin susceptible strains of _Pasteurella multocida,_
_Mannheimia haemolytica _and _Mycoplasma _spp.
Treatment of infections of the alimentary tract caused by enrofloxacin susceptible strains of _Escherichia coli_.
Treatment of septicaemia caused by enrofloxacin susceptible strains of _Escherichia coli_.
Treatment of acute mycoplasma-associated arthritis due to enrofloxacin susceptible strains of _Mycoplasma bovis_.
Pigs:
Treatment of infections of the respiratory tract caused by enrofloxacin susceptible strains of _Pasteurella multocida,_
_Mycoplasma _spp. and _Actinobacillus pleuropneumoniae_.
Treatment of infections of the alimentary tract caused by enrofloxacin susceptible strains of _Escherichia coli_.
Treatment of septicaemia caused by enrofloxacin susceptible strains of _Escherichia coli._
Dogs:
Treatment of infections of the alimentary, respiratory and urogenital tracts (including prostatitis, adjunctive antibiotic
therapy for pyometra), skin and wound infections, otitis (externa/media) caused by enrofloxacin susceptible strains of
_Staphylococcus _spp., _Escherichia coli_, _Pasteurella _spp., _Klebsiella _spp., _Bordetella _spp., _Pseudomonas _spp. and
_Proteus _spp.
1 ml of solution for injection contains:
ACTIVE SUBSTANCE:
Enrofloxacin
50 mg
EXCIPIENT(S):
n-butyl alcohol as antimicrobial preservative 30 mg
For the full list of excipie
Lees het volledige document
